Search PDMR transactions

Notifier
Name of person with notification obligation
Fredrik Lindgren
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Fredrik Lindgren
Position
Member of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Interim share LIPIGON PHARMACEUTICALS AB IA SE0021150927 Exercise increase 900,000 Quantity 0.20 SEK 07/06/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
LIPIGON PHARMACEUTICALS AB IA SE0021150927 Exercise increase 07/06/2024 NASDAQ STOCKHOLM AB 900,000 (Quantity) 0.20 SEK
Total: 900,000
<< Back